Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Immune-based therapies target senescent cell antigens, which include monoclonal antibodies, chimeric antigen receptor T-cells, and vaccines
Chapter 22: Structural and signaling functions of integrins
A research program funded by the Congressionally Directed Medical Research Programs is specifically investigating GLP-1R agonists as a new therapeutic for MS, recognizing that the benefits of calorie restriction on MS may be mediated partly through GLP-1 pathways
People with certain medical conditions, pregnant or nursing folks, or anyone on specific medications should chat with a healthcare provider first
US$ 26.40
US$ 28.85
US$ 27.96
